347
On 26 February 2013, the French Competition Authority (“Autorité de la concurrence”) announced the launch of a pharma sector inquiry. The Autorité ’s main goal is to address the cost of prescription medicines for social security, the high prices of non-reimbursable medicines, and the low level of (...)